News

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.
Add in the ongoing headlines surrounding Paramount and Skydance’s merger, which also seems to have the president in its orbit ...
As Europe’s healthcare systems grapple with aging populations, rising chronic disease, and overburdened clinicians, digital ...
The Global Metabolism Drugs Market, valued at approximately USD 16.10 billion in 2022, is projected to grow at a robust CAGR of more than 6.50% during the forecast period from 2023 to 2030. Metabolism ...
Parents is launching the first-ever Next Gen Awards, celebrating 40 changemakers helping families to get out of survival mode and thrive.
For many households, travel plans often go hand in hand with diet goals, whether it’s gearing up for beach season or simply ...
Simple lifestyle changes like diet, exercise and social support may prevent dementia and improve cognitive aging by up to two ...
DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus®DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus®DehydraTECH-GLP-1 s ...
The SELECT trial demonstrated a clear cardiovascular protection associated with semaglutide use, which could explain its ...
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics ...
Coca-Cola said it will start offering a version of its classic soda made with American cane sugar, following public push from ...